Filing Details

Accession Number:
0001121781-15-000197
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-17 17:06:19
Reporting Period:
2015-05-29
Filing Date:
2015-07-17
Accepted Time:
2015-07-17 17:06:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
924515 Guided Therapeutics Inc GTHP Electromedical & Electrotherapeutic Apparatus (3845) 582029543
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1348439 E John Imhoff 3215 Shrine Road
Suite 6
Brunswick GA 31520
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-29 18,752 $0.00 9,904,725 No 4 P Direct
Common Stock Acquisiton 2015-06-30 113,636 $0.00 9,885,973 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options Acquisiton 2015-05-29 600,000 $0.00 600,000 $0.10
Common Stock Tranche A Warrants Disposition 2015-06-19 367,647 $0.00 367,647 $1.08
Common Stock Tranche B Warrants Disposition 2015-06-19 3,797,789 $0.00 3,797,789 $0.10
Common Stock Tranche A Warrants Acquisiton 2015-06-19 367,647 $0.00 367,647 $0.10
Common Stock Tranche B Warrants Acquisiton 2015-06-19 3,797,789 $0.00 3,797,789 $0.09
Common Stock Warrants Disposition 2015-06-30 58,935 $0.00 58,935 $0.23
Common Stock Warrants Acquisiton 2015-06-30 58,935 $0.00 58,935 $0.11
Common Stock Warrants Acquisiton 2015-06-30 58,935 $0.00 58,938 $0.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
600,000 2015-05-29 2025-05-28 No 4 A Direct
0 2013-05-22 2018-05-22 No 4 S Direct
0 2013-05-22 2018-05-22 No 4 S Direct
367,647 2013-05-22 2018-05-22 No 4 P Direct
3,797,789 2013-05-22 2018-05-22 No 4 P Direct
0 2014-12-02 2019-12-02 No 4 S Direct
58,935 2015-12-02 2020-12-02 No 4 P Direct
58,935 2015-12-02 2020-12-02 No 4 P Direct
Footnotes
  1. On June 30, 2015, the reporting person disposed of warrants to purchase common stock in exchange for new warrants to purchase common stock and shares of common stock in an exchange with the issuer.
  2. These shares were granted as dividend on the issuer's Series B preferred stock.
  3. These options to purchase common stock were granted under the Guided Therapeutics, Inc. 1995 Stock Plan as amended; as 2015 director's fees, in lieu of cash. The options are 100% vested.
  4. On June 19, 2015, the reporting person disposed of warrants to purchase common stock in exchange for new warrants to purchase common stock in an exchange with the issuer.